COMPUGEN LTD Logo

COMPUGEN LTD

A clinical-stage company using AI to discover cancer immunotherapy drug targets.

CGEN | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
26 HAROKMIM STREET, 5885849 HOLON

Description

Compugen Ltd. is a clinical-stage therapeutic discovery and development company focused on cancer immunotherapy. The company utilizes a proprietary, predictive computational platform powered by artificial intelligence and machine learning to systematically identify novel drug targets and biological pathways. This technology enables the discovery and development of first-in-class and best-in-class therapeutics. Compugen's pipeline consists of immuno-oncology programs, including antibody-based product candidates, which are advanced through preclinical and clinical development stages.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2022-12-01 08:00
6-K
English ZIP 28.4 KB
2022-11-16 08:00
6-K
English ZIP 27.3 KB
2022-11-14 08:14
6-K
English ZIP 37.5 KB
2022-11-07 09:04
6-K
English ZIP 37.8 KB
2022-11-02 08:03
6-K
English ZIP 24.4 KB
2022-09-22 09:00
6-K
English ZIP 31.1 KB
2022-09-15 09:00
6-K
English ZIP 8.3 KB
2022-09-12 09:00
6-K
English ZIP 24.9 KB
2022-08-04 09:41
S-8
English ZIP 70.9 KB
2022-08-04 09:30
6-K
English ZIP 53.7 KB
2022-08-04 09:20
6-K
English ZIP 8.3 KB
2022-08-04 09:10
6-K
English ZIP 8.5 KB
2022-08-04 09:00
6-K
English ZIP 642.9 KB
2022-05-16 09:03
6-K
English ZIP 36.2 KB
2022-05-10 09:00
6-K
English ZIP 23.0 KB

Automate Your Workflow. Get a real-time feed of all COMPUGEN LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for COMPUGEN LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for COMPUGEN LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.